Clinical Investigation to Evaluate the Effectiveness and Safety of ECG App

NACompletedINTERVENTIONAL

Enrollment

673

Participants

Timeline

Start Date

April 2, 2021

Primary Completion Date

September 30, 2021

Study Completion Date

September 30, 2021

Conditions

Arrhythmias, Cardiac

Interventions

DEVICE

12-Lead ECG(I-lead)

All participants will simultaneously record 12-lead ECGs(I-lead)

Trial Locations (2)

The First Medical Center of the Chinese PLA General Hospital & Medical School, Beijing

The First Affiliated Hospital of Sun Yat-sen University, Guangzhou

All Listed Sponsors

lead

Huawei Device Co., Ltd

INDUSTRY

NCT05482503 - Clinical Investigation to Evaluate the Effectiveness and Safety of ECG App | Biotech Hunter | Biotech Hunter